329 related articles for article (PubMed ID: 32260430)
1. The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.
Steingruber M; Marschall M
Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32260430
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency.
Schütz M; Wangen C; Sommerer M; Kögler M; Eickhoff J; Degenhart C; Klebl B; Naing Z; Egilmezer E; Hamilton ST; Rawlinson WD; Sticht H; Marschall M
Virus Res; 2023 Oct; 335():199200. PubMed ID: 37591314
[TBL] [Abstract][Full Text] [Related]
3. The Interactive Complex between Cytomegalovirus Kinase vCDK/pUL97 and Host Factors CDK7-Cyclin H Determines Individual Patterns of Transcription in Infected Cells.
Schütz M; Cordsmeier A; Wangen C; Horn AHC; Wyler E; Ensser A; Sticht H; Marschall M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139252
[TBL] [Abstract][Full Text] [Related]
4. Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H.
Schütz M; Müller R; Socher E; Wangen C; Full F; Wyler E; Wong D; Scherer M; Stamminger T; Chou S; Rawlinson WD; Hamilton ST; Sticht H; Marschall M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233116
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations.
Wild M; Hahn F; Brückner N; Schütz M; Wangen C; Wagner S; Sommerer M; Strobl S; Marschall M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269635
[TBL] [Abstract][Full Text] [Related]
6. Functional Relevance of the Interaction between Human Cyclins and the Cytomegalovirus-Encoded CDK-Like Protein Kinase pUL97.
Schütz M; Steingruber M; Socher E; Müller R; Wagner S; Kögel M; Sticht H; Marschall M
Viruses; 2021 Jun; 13(7):. PubMed ID: 34198986
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
Bigley TM; Reitsma JM; Terhune SS
J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
[TBL] [Abstract][Full Text] [Related]
8. Regulatory roles of protein kinases in cytomegalovirus replication.
Marschall M; Feichtinger S; Milbradt J
Adv Virus Res; 2011; 80():69-101. PubMed ID: 21762822
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.
Steingruber M; Kraut A; Socher E; Sticht H; Reichel A; Stamminger T; Amin B; Couté Y; Hutterer C; Marschall M
Viruses; 2016 Aug; 8(8):. PubMed ID: 27548200
[TBL] [Abstract][Full Text] [Related]
10. Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97.
Steingruber M; Keller L; Socher E; Ferre S; Hesse AM; Couté Y; Hahn F; Büscher N; Plachter B; Sticht H; Marschall M
J Biol Chem; 2019 Apr; 294(15):6188-6203. PubMed ID: 30782840
[TBL] [Abstract][Full Text] [Related]
11. Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.
Webel R; Hakki M; Prichard MN; Rawlinson WD; Marschall M; Chou S
J Virol; 2014 May; 88(9):4776-85. PubMed ID: 24522923
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.
Marschall M; Stein-Gerlach M; Freitag M; Kupfer R; van den Bogaard M; Stamminger T
J Gen Virol; 2001 Jun; 82(Pt 6):1439-1450. PubMed ID: 11369889
[TBL] [Abstract][Full Text] [Related]
13. Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy.
Marschall M; Stein-Gerlach M; Freitag M; Kupfer R; van den Bogaard M; Stamminger T
J Gen Virol; 2002 May; 83(Pt 5):1013-1023. PubMed ID: 11961255
[TBL] [Abstract][Full Text] [Related]
14. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.
Bigley TM; Reitsma JM; Mirza SP; Terhune SS
J Virol; 2013 Jul; 87(13):7393-408. PubMed ID: 23616659
[TBL] [Abstract][Full Text] [Related]
16. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
Piret J; Boivin G
Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
[TBL] [Abstract][Full Text] [Related]
17. The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins.
Graf L; Webel R; Wagner S; Hamilton ST; Rawlinson WD; Sticht H; Marschall M
Viruses; 2013 Dec; 5(12):3213-30. PubMed ID: 24351800
[TBL] [Abstract][Full Text] [Related]
18. The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain.
Steingruber M; Socher E; Hutterer C; Webel R; Bergbrede T; Lenac T; Sticht H; Marschall M
Viruses; 2015 Aug; 7(8):4582-601. PubMed ID: 26270673
[TBL] [Abstract][Full Text] [Related]
19. Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1.
Syrigos GV; Feige M; Dirlam A; Businger R; Gruska I; Wiebusch L; Hamprecht K; Schindler M
Antiviral Res; 2023 Sep; 217():105689. PubMed ID: 37516154
[TBL] [Abstract][Full Text] [Related]
20. The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors.
Hutterer C; Hamilton S; Steingruber M; Zeitträger I; Bahsi H; Thuma N; Naing Z; Örfi Z; Örfi L; Socher E; Sticht H; Rawlinson W; Chou S; Haupt VJ; Marschall M
Antiviral Res; 2016 Oct; 134():130-143. PubMed ID: 27515131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
